➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Medtronic
AstraZeneca
Express Scripts
Harvard Business School

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

DOXAPRAM HYDROCHLORIDE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for doxapram hydrochloride and what is the scope of patent protection?

Doxapram hydrochloride is the generic ingredient in two branded drugs marketed by Hikma, Athenex Inc, and Watson Labs, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for doxapram hydrochloride. Two suppliers are listed for this compound.

Recent Clinical Trials for DOXAPRAM HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Erasmus Medical CenterPhase 3
Nederlands Neonataal Netwerk (N3), the NetherlandsPhase 3
Universitaire Ziekenhuizen LeuvenPhase 3

See all DOXAPRAM HYDROCHLORIDE clinical trials

Pharmacology for DOXAPRAM HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DOXAPRAM HYDROCHLORIDE

US Patents and Regulatory Information for DOXAPRAM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma DOPRAM doxapram hydrochloride INJECTABLE;INJECTION 014879-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Watson Labs DOXAPRAM HYDROCHLORIDE doxapram hydrochloride INJECTABLE;INJECTION 073529-001 Jan 30, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Athenex Inc DOXAPRAM HYDROCHLORIDE doxapram hydrochloride INJECTABLE;INJECTION 076266-001 Jan 10, 2003 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Mallinckrodt
Medtronic
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.